NM_000552.5:c.2435delC
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000552.5(VWF):c.2435delC(p.Pro812ArgfsTer31) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000552.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 28AN: 250878Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135654
GnomAD4 exome AF: 0.0000732 AC: 107AN: 1461760Hom.: 0 Cov.: 30 AF XY: 0.0000853 AC XY: 62AN XY: 727172
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74322
ClinVar
Submissions by phenotype
not provided Pathogenic:6Other:1
- -
- -
This frameshift variant alters the translational reading frame of the VWF mRNA and causes the premature termination of VWF protein synthesis. The frequency of this variant in the general population, 0.00054 (14/26126 chromosomes, http://gnomad.broadinstitute.org), is consistent with pathogenicity. In the published literature, the variant has been described as a common mutation in the Swedish and Finnish populations (PMIDs: 1302613 (1992), 23834637 (2013)), reported in heterozygous patients with vWD type I (PMIDs: 16985174 (2007), 17190853 (2007)), and in homozygous or compound heterozygous patients with vWD type III (PMIDs: 23834637 (2013), 29427305 (2018), 35343054 (2022)). Based on the available information, this variant is classified as pathogenic. -
VWF: PVS1, PM2 -
- -
The VWF c.2435del; p.Pro812Argfs*31 variant (rs62643632; ClinVar Variation ID: 303), is the index variant for von Willebrand disease (VWD) associated with VWD type 3, and is considered a founder variant in Baltic populations (Jokela 2013, Zhang 1993). This variant causes a frameshift by deleting a single nucleotide, and a functional study has shown no protein expression from the affected allele, suggesting the mRNA is subject to nonsense-mediated decay (Flood 2012). Based on available information, this variant is considered to be pathogenic. REFERENCES: Flood VH et al. Critical von Willebrand factor A1 domain residues influence type VI collagen binding. J Thromb Haemost. 2012 Jul;10(7):1417-24. PMID: 22507569. Jokela V et al. Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations. Haemophilia. 2013 Nov;19(6):e344-8. PMID: 23834637. Zhang ZP et al. Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland Islands. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7937-40. PMID: 8367445. -
- -
von Willebrand disease type 1 Pathogenic:3
- -
ACMG Criteria: PVS1, PM2, PP5; Variant was found in heterozygous state -
Criteria applied: PVS1,PS4,PS3_MOD -
von Willebrand disease type 3 Pathogenic:2
- -
- -
Hereditary von Willebrand disease Pathogenic:1Other:1
- -
- -
von Willebrand disease type 2 Pathogenic:1
Criteria applied: PVS1,PM3,PM2_SUP; Identified as compund heterozygous with NM_000552.5:c.2561G>A -
von Willebrand disease type 1;C1264040:von Willebrand disease type 2;C1264041:von Willebrand disease type 3 Pathogenic:1
- -
Abnormal bleeding Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at